Vaccin quadrivalent HPV: des résultats encourageants pour la prévention du cancer du col de l'utérus : Le Col de l'utérus = Human papillomavirus vaccine for the prevention of cervical cancerRIETHMULLER, D; LEOCMACH, Y; JACQUARD, A. C et al.La Lettre du cancérologue (Boulogne). 2007, Vol 16, Num 5, issn 1165-113X, 164Article

Vaccin quadrivalent HPV : des résultats encourageants pour la prévention du cancer du col de l'utérus : Oncologie gynécologique = Human papillomavirus vaccine for the prevention of cervical cancerRIETHMULLER, D; LEOCMACH, Y; JACQUARD, A.-C et al.La Lettre du gynécologue. 2006, Num 315, pp 37-37, issn 0759-1594, 1 p.Article

Efficacy and tolerability of a low-dose of Oesclim® (25 mcg daily) in the management of symptomatic menopausal women : A French Open-Label StudyELIA, D; TAMBORINI, A; LEOCMACH, Y et al.Current medical research and opinion. 2000, Vol 16, Num 2, pp 94-106, issn 0300-7995Article

HPV vaccination among French girls and women aged 14-23 years and the relationship with their mothers' uptake of Pap smear screening: A study in general practiceLUTRINGER-MAGNIN, D; CROPET, C; BARONE, G et al.Vaccine. 2013, Vol 31, Num 45, issn 0264-410X, S243-S249Article

Cardiovascular risk markers associated with the metabolic syndrome in a large French population : the SYMFONIE studyPANNIER, B; THOMAS, F; ESCHWEGE, E et al.Diabetes & metabolism. 2006, Vol 32, Num 5, pp 467-474, issn 1262-3636, 8 p., 1Article

Efficacy and tolerability of low-dose transdermal estrogen (oesclim®)^* in the treatment of menopausal symptomsGADOMSKA, H; BARCZ, E; CYGANEK, A et al.Current medical research and opinion. 2002, Vol 18, Num 2, pp 97-102, issn 0300-7995Article

Human papillomavirus (HPV) vaccination: Perception and practice among French general practitioners in the year since licensingLUTRINGER-MAGNIN, D; KALECINSKI, J; BARONE, G et al.Vaccine. 2011, Vol 29, Num 32, pp 5322-5328, issn 0264-410X, 7 p.Article